Urinary Acetaminophen Metabolites and Clinical Outcomes in Extremely Premature Infants
American Journal of Perinatology · 01.09.2025 · 42 (12) · 1576-1587
DOI: 10.1055/a-2512-9387 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift American Journal of Perinatology, erschienen am 01.09.2025. Verfasst von Miguel Guardado und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological and Medical Informatics, University of California, San Francisco, San Francisco, California. Hauptthemen laut MEDLINE: Infant, Extremely Premature, Acetaminophen, Bronchopulmonary Dysplasia, Retinopathy of Prematurity. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, NIH grants.
Themen: Neonatologie
Abstract (Originalsprache)
Extremely premature infants are treated with acetaminophen (APAP) for pain and patent ductus arteriosus. High doses of APAP in adults are toxic, and a recent study found an association between APAP metabolite levels in mothers' breast milk and both bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) in their premature infants. In this study, we determined levels of APAP metabolites in the urine of infants at high risk for BPD and ROP. Biorepository urine samples from 314 infants
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biological and Medical Informatics, University of California, San Francisco, San Francisco, California.
- Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.
- Department of Pediatrics, University of California, San Francisco, San Francisco, California.
- Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California.
- Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
- Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Förderung
- NIGMS NIH HHS
- NHLBI NIH HHS
- NIH grants
Zitieren
APA
Guardado, M., Torgerson, D., Chapin, C., Atum, A., Hernandez, R. D., Clyman, R., Simmons, R., Parry, S., & Ballard, P. L. (2025). Urinary Acetaminophen Metabolites and Clinical Outcomes in Extremely Premature Infants. American Journal of Perinatology, 42(12), 1576-1587. https://doi.org/10.1055/a-2512-9387
Vancouver
Guardado M, Torgerson D, Chapin C, Atum A, Hernandez RD, Clyman R, et al. Urinary Acetaminophen Metabolites and Clinical Outcomes in Extremely Premature Infants. American Journal of Perinatology. 2025;42(12):1576-1587. doi:10.1055/a-2512-9387
BibTeX
@article{Guardado2025,
author = {Guardado, Miguel and Torgerson, Dara and Chapin, Cheryl and Atum, Azuka and Hernandez, Ryan D and Clyman, Ronald and Simmons, Rebecca and Parry, Samuel and Ballard, Philip L},
title = {Urinary Acetaminophen Metabolites and Clinical Outcomes in Extremely Premature Infants},
journal = {American Journal of Perinatology},
year = {2025},
volume = {42},
number = {12},
pages = {1576--1587},
doi = {10.1055/a-2512-9387}
}
EUVIMED